数据链接：
官方服务：
资源简介：
Melanoma CTC counts and PD-L1 positive CTCs.
应用场景：
创建时间：
2019-02-08
相关数据集
Comparison of 133/144bp dominant phenotype vs 166bp dominant phenotype.
Background: Previous studies found that cell-free DNA (cfDNA) generated from tumors was shorter than that from healthy cells, and selecting short cfDNA could enrich for tumor cfDNA and improve its usa
NIAID Data Ecosystem100
Supplementary Table 1 from A Quantitative Analysis of Subclonal and Clonal Gene Mutations before and after Therapy in Chronic Lymphocytic Leukemia
Detailed patient characteristics and treatment details
NIAID Data Ecosystem70
Data_Sheet_1_Circulating Tumor DNA as a Potential Marker to Detect Minimal Residual Disease and Predict Recurrence in Pancreatic Cancer.docx
Pancreatic ductal adenocarcinoma (PDAC) is one of the leading causes of cancer death, partly due to the high recurrence rates for patients with PDAC. Current postoperative surveillance methods, includ
NIAID Data Ecosystem30
Additional file 4: of Targeted sequencing of circulating cell-free DNA in stage II-III resectable oesophageal squamous cell carcinoma patients
Details of all somatic mutations. Coding sequence mutations, amino acid changes, CADD score, ALT read counts and MAF for tumour, pre-surgery plasma, post-surgery plasma, and WBC are listed. (XLSX 42 k
Figshare2024-02-15 更新90
Additional file 3 of Patient specific circulating tumor DNA fingerprints to monitor treatment response across multiple tumors
Additional file 3: Table S3. Acquired drug-related mutations in nine patients identified using a pre-designed ctDNA panel.
NIAID Data Ecosystem40
